MDTMedtronic

1. Sep 17, 2026On September 14, 2026, Medtronic plc, a public limited company organized under the laws of Ireland (“Medtronic”), commenced an offer to exchange (the “Exchange Offer”) up to 225,361,295 newly issued shares of common stock, par value $0.01 per share (“MiniMed Common Stock”), of MiniMed Group, Inc., a Delaware …Other event · Form 8-K
2. Sep 1, 2026Medtronic reports first quarter fiscal 2027 results; delivers broad-based portfolio performance and raises fiscal 2027 guidance.Earnings release · press release
3. Jun 3, 2026Medtronic reports fourth quarter and full year fiscal 2026 results; delivers highest annual revenue growth in 10 years.Earnings release · press release
4. May 18, 2026On May 18, 2026, Medtronic plc (“Medtronic” or the “Company”) announced that Brett Wall will be departing from his position as Executive Vice President and President, Neuroscience Portfolio, and that Dr. Kweli Thompson, currently Senior Vice President and President, Cardiac Rhythm Management, will be assuming the role …Director or officer change · Form 8-K
5. Apr 27, 2026Medtronic statement on unauthorized system access.Regulation FD disclosure · press release
6. Feb 17, 2026Medtronic reports strong third quarter.Earnings release · press release
7. Nov 18, 2025Medtronic reports strong second quarter.Earnings release · press release
8. Nov 3, 2025On November 1, 2025, Gregory L. Smith, Executive Vice President, Enterprise Operations of Medtronic plc (the Company), notified the Company of his decision to retire from the Company, effective December 2, 2025, and to join a private equity-held organization.Director or officer change · Form 8-K
9. Oct 21, 2025Amendments to Articles of Incorporation or Bylaws As disclosed in Proposals 7 and 9 of the definitive proxy statement of Medtronic plc (“Medtronic” or the “Company”), as filed with the Securities and Exchange Commission on August 25, 2025 (the “Proxy Statement”), in connection with the Company’s 2025 Annual General …Charter/bylaw amendment or fiscal-year change · Form 8-K
10. Sep 29, 2025Notes Offering On September 29, 2025, Medtronic, Inc., an indirect wholly owned subsidiary of Medtronic public limited company (“Medtronic plc”), issued €750,000,000 aggregate principal amount of its 2.950% Senior Notes due 2030 (the “2030 Notes”) and €750,000,000 aggregate principal amount of its 4.200% Senior Notes …Material agreement entered · Form 8-K
11. Sep 16, 2025Underwriting Agreement On September 15, 2025, Medtronic, Inc., Medtronic plc and Medtronic Luxco entered into an underwriting agreement (the “Underwriting Agreement”) with the underwriters listed therein, for which Deutsche Bank AG, London Branch and Goldman Sachs & Co. LLC acted as representatives.Regulation FD disclosure · Form 8-K

Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.